Members of EMA's eligible organisation also have training initiatives that promote a better understanding of the development and approval of medicines as well as the involvement of patients and consumers in these processes. While EMA takes care in selecting external websites, it accepts no responsibility for the content:

• The European Patients' Academy (EUPATI) is a pan-European Innovative Medicines Initiative project of 33 organisations, led by the European Patients' Forum, with partners from patient organisations, universities and not-for-profit organisations, along with a number of European pharmaceutical companies. It provides scientifically reliable, objective and comprehensive information to patients on medicines research and development.
• The Open Academy School on Medicines Research & Development helps prepare patients for advocating for medicines development, equal access to treatments across Europe and ensuring that medical information is clear, accurate and comprehensible. EURORDIS launched this training programme for patient experts in 2008.
• The European Patient Ambassador Programme (EPAP) is a self-learning programme introducing patients and carers to the essential skills and knowledge needed to interact with healthcare professionals, policy-makers, researchers and journalists. The training programme was developed by the European Lung Foundation and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Leeds, York and Bradford, with the help of patients, and professionals with expertise in key areas.